Activation of group 2 innate lymphoid cells via TL1A/DR3: A Solution to corticosteroid resistance?

Chrysanthi Skevaki; Markus Weckmann

doi:10.1164/rccm.202007-2658ED

Activation of group 2 innate lymphoid cells via TL1A/DR3: A Solution to corticosteroid resistance?

Clinic of Pediatric and Adolescent Medicine

University of Marburg

Original language	English
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	202
Issue number	8
Pages (from-to)	1067-1069
Number of pages	3
ISSN	1073-449X
DOIs	https://doi.org/10.1164/rccm.202007-2658ED
Publication status	Published - 15.10.2020

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

DFG Research Classification Scheme

2.22-20 Pediatric and Adolescent Medicine
2.21-05 Immunology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1164/rccm.202007-2658ED

Cite this

@article{2eaec4882d0d4543b18a9ecd67354d8f,

title = "Activation of group 2 innate lymphoid cells via TL1A/DR3: A Solution to corticosteroid resistance?",

author = "Chrysanthi Skevaki and Markus Weckmann",

note = "Funding Information: C.S. is supported by the Universities Giessen and Marburg Lung Center; the German Center for Lung Research (DZL); University Hospital Giessen and Marburg research funding according to article 2, section 3 cooperation agreement; and the Deutsche Forschungsgemeinschaft-funded SFB 1021 (C04), KFO 309 (P10), and SK 317/1-1 (project number 428518790). M.W. is supported by the DZL and the University of L{\"u}beck (E42-2012 and JC01-2016). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2020",

month = oct,

day = "15",

doi = "10.1164/rccm.202007-2658ED",

language = "English",

volume = "202",

pages = "1067--1069",

journal = "American Journal of Respiratory and Critical Care Medicine",